{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-023257","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.662619+00:00","generated_at":"2026-06-05T07:14:02.697769+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Janux Therapeutics prices $296.5M public offering of common stock and pre-funded warrants","bullets":["Pricing: 4,440,851 shares at $46.50/share and pre-funded warrants to purchase 1,935,483 shares at $46.499.","Gross proceeds ~$296.5M, up from initial $175M offering; underwriters have 30-day option for 956,450 shares.","Proceeds to fund clinical pipeline development and general corporate purposes; close expected March 4, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-023257","json":"https://secwatch.observer/filing/0000950170-24-023257.json","markdown":"https://secwatch.observer/filing/0000950170-24-023257.md","text":"https://secwatch.observer/filing/0000950170-24-023257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024023257/0000950170-24-023257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024023257/janx-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T07:14:02.697769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}